StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BTIG Downgrades Teva Pharma (TEVA) to Neutral
January 18, 2018 1:42 PM
BTIG downgraded Teva Pharma (NYSE: TEVA) from Buy to Neutral.Analyst Timothy Chiang commented, "We lower our rating on TEVA shares ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Downgrades
Next Articles
Generic Weakness Creates Buying Opportunity - Mizuho
January 18, 2018 11:18 AM
Teva (TEVA), Peer Weakness Said tied to Report Hospital System Plans to Create Drug Company
January 18, 2018 9:54 AM
CTI BioPharma (CTIC) Announces $10M Milestone Payment from Teva Pharmaceuticals (TEVA) for TRISENOX
January 18, 2018 5:44 AM
Teva Pharma (TEVA) Granted FDA Approval of TRISENOX (arsenic trioxide) Injection
January 16, 2018 5:43 AM